Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

How "Clean" Will PDFUA V Be? Rep. Pitts Explains His Vacuuming Technique

Executive Summary

Pennsylvania Republican Joe Pitts, chairman of the House Energy and Commerce Health Subcommittee, has a straightforward approach to reauthorizing the Prescription Drug User Fee Act – get it done early.
Advertisement

Related Content

FDA Wants Authority To Enforce Track-And-Trace System For Drugs
Lilly's Field Of Dreams: "Campaign For Modern Medicines" Wants A Clean PDUFA
Generic Drug User Fees Will Begin With The Backlog
What’s In A PDUFA Reauthorization? Maybe These Issues…
What’s In A PDUFA Reauthorization? Maybe These Issues…
FDA Approval Standards Need To Be Relaxed, Venture Capitalists Say
Generic User Fee Talks: Performance Metrics For Early Years Still Unresolved
Woodcock Defends Speed Of FDA Reviews, Cites 20 Approvals In First Half Of 2011
BIO’s "Big Ideas" For FDA Reform Are Too Big For PDUFA
U.S. Legislative Response to Heparin Crisis Begins to Take Shape

Topics

Advertisement
UsernamePublicRestriction

Register

PS053603

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel